It also re-examines some of the conventional wisdom that previously dominated clinical trial design and discusses development and internal validation of a predictive biomarker as a new paradigm for ...
Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma Innovations in molecular biology and immunology have revealed that distinct cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results